Aug 12: Laxmi Dental Limited, a leading integrated dental products company, announced its Audited Financial Results for the quarter ended June 30th, 2026.
The company’s Q1 FY27 PAT jumps 23.8% to INR 103.2 million as against INR 83.3 million in Q1 FY26. It reported revenue of INR 747 million in Q1 FY27 as compared to INR 656 million in Q1 FY26, marking an increase of 13.9% year-on-year.
EBITDA stood at INR 143.6 million in Q1 FY27 as compared to INR 119.1 million in Q1 FY26, reflecting a 20% growth year-on-year.
Key financial highlights for Q1 FY27:
- Highest-ever quarterly revenue with 13.9% YoY growth.
- Gross margins stood at 78.6%, which is a year-on-year and sequential improvement; driven by change in product mix.
- Gross Margins for the Core Dental Business excluding scanner sales has marginally improved.
- Scanner sales contribution for the quarter was minimal.
- ESOP expenses, which are non-cash in nature, amounted to INR 8.3 Mn in Q1 FY27 as against INR 18.4 Mn in Q1 FY26.
Commenting on the performance Mr. Rajesh Khakhar, Chairperson and Whole-Time Director said, “We are pleased to report a strong start to FY27, with Q1 revenue reaching our highest-ever quarterly level of around ₹75.0 crore, representing year-on-year growth of 13.9%. The performance was broad-based, led by healthy momentum in our Dental Laboratory business and our Aligner Solutions business. Our profitability during the quarter witnessed some improvement largely on account of a better product mix.
We are strengthening our on-ground leadership presence in the U.S. to sharpen our market-focused strategy and sustain healthy growth in this market. In India, we have established 3 new support facilities across multiple cities to deepen our regional presence, enhance market penetration and provide better service to our existing dental partners.
Going forward, a focus on core dental portfolio, deeper market penetration, AI-led automation, and improving operational efficiencies enables Laxmi Dental to deliver healthy and sustainable performance.”
Commenting on the performance Mr. Sameer Merchant, Managing Director and CEO said, “Our robust performance in Q1FY27 reflects the sustained efforts of our sales and operations teams, supported by scanner deployments in the past, training programs, promotional activities, participation in dental events and digital initiatives.
For the quarter our dental laboratory business grew by 23.5% year-on-year, with international operations registering particularly strong growth of 37.4%, reflecting our relationships and market presence across global markets.
Aligner Solutions business also maintained its momentum, growing 28.6% year-on-year, with both Bizdent and Vedia delivering healthy growth of 27.8% and 29.3% respectively.
With continued progress in digitalization, innovation, branding and dental network expansion, we remain well positioned to deliver sustainable and profitable growth for the upcoming years.”